bpc 157 ed Peptides like BPC-157, TB-500, and growth hormone secretagogues are increasingly marketed for recovery and injury healing. But what does the science actually say? - Most evidence comes from animal studies Christopher Mendias, PhD, gets four

You dont have to guess what treatment is right for you

The total human evidence base, as of this writing, consists of the following: 1) a Phase I safety trial of 42 healthy volunteers that was registered in 2015, canceled in 2016, and never published, 2) a retrospective case series of 12 patients with knee pain, no control group, and no validated outcome measure, and 3) a 2025 pilot safety study involving two healthy adults who received intravenous infusions at a single private clinic in Florida

Oral NAD+ Precursor Ranges from Published Trials Precursor Nicotinamide Riboside (NR) Dose 300-1,000 mg Frequency Daily Trial signal Multiple human RCTs raised blood NAD+ with favorable tolerability

With over 10 years experience, Dr